PT151.S3.Q3 > Question

SECTION 1 · rc

PASSAGE 1

Question 1 Question 2 Question 3 Question 4 Question 5 Question 6

PASSAGE 2

Question 7 Question 8 Question 9 Question 10 Question 11 Question 12 Question 13 Question 14

PASSAGE 3

Question 15 Question 16 Question 17 Question 18 Question 19 Question 20 Question 21

PASSAGE 4

Question 22 Question 23 Question 24 Question 25 Question 26 Question 27

SECTION 2 · lr

Question 1 Question 2 Question 3 Question 4 Question 5 Question 6 Question 7 Question 8 Question 9 Question 10 Question 11 Question 12 Question 13 Question 14 Question 15 Question 16 Question 17 Question 18 Question 19 Question 20 Question 21 Question 22 Question 23 Question 24 Question 25 Question 26

SECTION 3 · lr

SECTION 4 · lr

Dario says that patents should be granted for all new drugs. Why? Because patents promote innovation. Dario supports this major premise by explaining that patents reward pharmaceutical companies for spending money on researching new drugs.

Cynthia thinks that patents should only be granted for “truly innovative” new drugs, not absolutely all new drugs. Cynthia also supports this proposal by saying it will promote innovation. So how does limiting patents help innovation? Because it would deter companies from just developing variations on existing drugs, which is cheaper than coming up with truly new drugs.

We’re looking for a point of disagreement. Dario and Cynthia disagree about whether absolutely all new drug developments should be rewarded with patents.

Both Dario and Cynthia agree with this. Both speakers want to encourage innovation by offering pharmaceutical companies rewards, they just disagree on what counts as innovation.

Dario agrees with this, but Cynthia disagrees: here’s the point of disagreement. This claim is Dario’s main conclusion. Cynthia’s conclusion, however, is that only certain drug compounds should get patents.

Both speakers agree that this is true. Dario talks about the “costly” research needed to develop any new drugs, and Cynthia says that varying existing drugs is “much less expensive” than innovative drugs (meaning innovation is much more expensive).

Cynthia agrees with this, but Dario doesn’t express an opinion about minor variants specifically. Dario groups all sorts of new drugs together, and never distinguishes between minor variants and totally new drugs.

Both speakers agree with this claim. Both Dario and Cynthia think that awarding patents can promote innovation, they just disagree about when precisely the decision to award patents should be made.

PrepTest 151 - Section 3 - Question 3

Difficulty

Analysis

Answer Popularity

Question history

Confirm action